本页面由Tiger Trade Technology Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

32.56
+0.79002.49%
盘后33.000.4400+1.35%19:48 EDT
成交量:106.94万
成交额:3,501.13万
市值:19.26亿
市盈率:-280.05
高:33.83
开:32.25
低:31.51
收:31.77
52周最高:40.22
52周最低:5.35
股本:5,915.08万
流通股本:4,393.78万
量比:0.91
换手率:2.43%
股息:- -
股息率:- -
每股收益(TTM):-0.1163
每股收益(LYR):-0.1163
净资产收益率:-2.37%
总资产收益率:-3.73%
市净率:5.46
市盈率(LYR):-280.05

数据加载中...

2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

重要事件披露

Form 8-K - Current report
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

重要事件披露

Form 8-K - Current report
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]